CIK 0001509261
- Non-accelerated filer
- Smaller reporting company
Rezolute, Inc.
Sign in to watch- Ticker
- RZLT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 273440894
- Phone
- +1 650-206-4507
- Business address
- 275 SHORELINE DRIVE, SUITE 500, REDWOOD CITY, CA, 94065
- Former names
- AntriaBio, Inc., FITS MY STYLE INC
- 4 Grant or award Director acquired 21,000 shares (grant or award)
- 4 Grant or award Director acquired 21,000 shares (grant or award)
- 4 Grant or award Director acquired 21,000 shares (grant or award)
- 4 Grant or award Director acquired 21,000 shares (grant or award)
- 4 Grant or award Chief Commercial Officer acquired 25,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Chief Medical Officer bought 2,500 shares at $4.38 ($10,939)
- 4 Open-market buy CFO bought 5,000 shares at $4.05 ($20,250)
- 4 Open-market buy Director bought 1,230,769 shares at $3.25 ($3,999,999)
- 4 Open-market buy Director bought 3,076 shares at $3.25 ($9,997)
- 4 Grant or award Director acquired 9,000 shares (grant or award)
- 4 Grant or award Director acquired 9,000 shares (grant or award)
- 4 Grant or award Director acquired 9,000 shares (grant or award)
- 4 Grant or award Director acquired 9,000 shares (grant or award)
- 4 Grant or award CFO acquired 26,000 shares (grant or award)
- 4 Grant or award Director acquired 9,000 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 26,000 shares (grant or award)
- 4 Grant or award CEO acquired 68,000 shares (grant or award)
- 4 Open-market buy Director bought 6,758 shares at $2.92 ($19,733)
- 4 Open-market buy CEO bought 12,302 shares at $2.85 ($34,999)
Page 2 of 11 · 208 filings